Search

Recent news

BEAM Alliance 10th AMR meeting 2026, Basel

Last week, CSO Mat Upton and CEO Gordon Barker travelled to Basel, Switzerland for the BEAM Alliance 10th AMR meeting.…

Amprologix attends International Biotechnology Achievement Forum in Riyadh

On 14th December, CSO Mat Upton was invited to attend the Final Forum of the Saudi Biotechnology Accelerator (SBA) in…

Amprologix Celebrates Research Excellence at the University of…

Amprologix celebrates research excellence at the University of Plymouth as CSO Professor Mat Upton presents the Research Excellence Award to…

Amprologix secures £740,000 investment to accelerate development of…

Amprologix has raised £740,000 to accelerate the development of our breakthrough antibiotic Epidermicin NI01. This investment also supports our AI-driven…

LSX World Congress

Amprologix to Attend LSX World Congress in Boston

We are pleased to announce that Professor Mat Upton, Chief Scientific Officer at Amprologix, will represent the company at the…

News articles

2 June 2025
Amprologix Selected for MassChallenge Switzerland & UK 2025 Accelerator

Amprologix joins a global network of innovators We're proud to announce that Amprologix is one of the 103 finalists selected to participate in the MassChallenge Switzerland & UK Accelerator Programme 2025, chosen from a pool of 1,527 high-potential startups worldwide. This milestone places Amprologix among a global community of science-driven innovators who are committed to […]

Read More
linkedin facebook pinterest youtube rss twitter instagram facebook-blank rss-blank linkedin-blank pinterest youtube twitter instagram